MustGrow and Bayer sign Exclusive Agreement to develop sustainable organic biologicals in Europe, Asia Pacific, Middle East and Africa

Bayer to commercialise biopesticides from mustard seed

  • Exclusive agreement with Bayer to evaluate MustGrow’s technologies to determine commercial potential.
  • Bayer has the option to acquire exclusive rights to MustGrow’s technologies for preplant soil fumigation, bioherbicide applications and postharvest food preservation of potatoes including sprout inhibition in the regions of Europe, Asia Pacific, Middle East and Africa.
  • Bayer will fund and drive all laboratory, field development, regulatory work and market development.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (“MustGrow”) and Bayer have signed an Exclusive Agreement to evaluate MustGrow’s biological technologies to determine efficacy and commercial potential in key agricultural regions. Sustainable innovations and green technologies are necessary to ensure agricultural production continues to address food safety and security as well as soil health. This agreement between Bayer and MustGrow further demonstrates the importance of innovation in sustainable technologies in agricultural regions around the world.

MustGrow has granted Bayer the right to use MustGrow’s intellectual property for testing purposes and the option to acquire exclusive rights to MustGrow’s technologies for preplant soil fumigation, bioherbicide applications, and postharvest food preservation of potatoes, including sprout inhibition in the regions of Europe, Asia Pacific, Middle East and Africa. Under the agreement, Bayer will fund and drive all laboratory, field development, regulatory work and market development necessary for commercialization. MustGrow continues to conduct field trials, R&D and regulatory development concurrently in other regions, collaborating with numerous agriculture, chemical products, and consumer food companies.

MustGrow’s technology pipeline is focused on remarkably safe, effective, organic plant-based biopesticides that harness the mustard seed’s natural defense mechanism to treat diseases, pests and weeds. MustGrow’s technology has shown consistent efficacy in many regions of North and South America, in multiple crops, covering many pests, over multiple years.

“We are thrilled to accelerate the development and understanding of our technology with Bayer in these important food producing regions. I am hopeful that we potentially have a sustainable solution for farmers to help with key issues in their production of food,” said Corey Giasson, CEO of MustGrow. “Working with a leading global agricultural company like Bayer, who is focused on sustainable agriculture, is a tremendous opportunity for our organization to see our technologies develop globally.”

“At Bayer we know that the challenges facing agriculture, both now and in the future, cannot be solved alone and we are looking forward to working with MustGrow,” said Benoit Hartmann, Head of Biologics for Bayer Crop Science. “This new agreement will help Bayer to understand the potential of MustGrow’s novel biopesticide technologies and how they can accelerate development of sustainable crop protection.”

Europe, Asia Pacific, Middle East and Africa are expected to have represented roughly 56% of the global crop protection market in 2021. The global market is projected to have grown nearly 3% in 2021, with the Asia market leading this growth.1 The worldwide biopesticide market is expected to grow at a compound annual growth rate of 13.1% and reach US$10.63 billion by 2027, driven by increased demand for organic food, elimination of synthetic chemical alternatives and intensifying efforts by governments and industry to use more sustainable products.2

Sources:

About MustGrow

MustGrow is a publicly traded (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) agriculture biotech company focused on providing natural science-based biological solutions for high value crops, including fruits & vegetables and other industries. MustGrow has designed and owns a U.S. EPA-approved natural solution that uses the mustard seed’s natural defence mechanism to protect plants from pests and diseases. Over 110 independent tests have been completed, validating MustGrow’s safe and effective signature products. The product, in granule format, is EPA-approved across all key U.S. states and by Health Canada’s PMRA (Pest Management Regulatory Agency) as a biopesticide for high value crops such as in fruit & vegetables. MustGrow has now concentrated a mustard extract biopesticide in liquid format, TerraMG, and with regulatory approval, could be applied through standard drip or spray equipment, improving functionality and performance features. In addition, the Company’s mustard-derived extract technologies could have other applications in several different industries from preplant soil treatment, to weed control, to post harvest disease control and food preservation.

The Company has approximately 47.8 million basic common shares issued and outstanding and 54.7 million shares fully diluted.


Contact

“Corey Giasson”
Director & CEO
Phone: +1-306-668-2652
E-Mail: info@mustgrow.ca

Source

MustGrow, press release, 2022-01-21.

Supplier

Bayer AG
MustGrow Biologics Corp.

Share

Renewable Carbon News – Daily Newsletter

Subscribe to our daily email newsletter – the world's leading newsletter on renewable materials and chemicals

Subscribe